Abstract
The clinical use of anti-oestrogens in breast cancer therapy has traditionally been restricted to tumours that contain measurable oestrogen receptor protein. However, it is now widely recognised that the clinical response to adjuvant anti-oestrogen therapy appears to be independent of the oestrogen receptor content of the primary tumour. The study reported here was designed to investigate the possibility that human stromal cells can respond to anti-oestrogens by an increased synthesis of the inhibitory growth factor, transforming growth factor beta (TGF-beta). Two established human fetal fibroblast strains were used as models for the breast cancer stromal fibroblasts. These cells were found to respond to the addition of anti-oestrogens by a large increase in their synthesis of biologically active TGF-beta. Despite the application of ligand binding, immunoassay and Northern analysis, no oestrogen receptor or oestrogen receptor mRNA was detected in either of the human fetal fibroblasts strains. These observations may provide a mechanism of action of anti-oestrogens that is independent of the presence of oestrogen receptor in the tumour epithelial cells, and thus provide an explantation for the counter-intuitive results of adjuvant anti-oestrogen action.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Colletta, A., Wakefield, L., Howell, F. et al. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer 62, 405–409 (1990). https://doi.org/10.1038/bjc.1990.307
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.307
This article is cited by
-
Review of non-surgical treatment options for Peyronie's Disease
International Journal of Impotence Research (2012)
-
Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications
Breast Cancer Research and Treatment (2010)
-
Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?
Breast Cancer Research and Treatment (2009)
-
Peyronie's disease: a critical appraisal of current diagnosis and treatment
International Journal of Impotence Research (2008)